Instructions for Vicair tablets blister No. 10
Composition
active ingredients: 1 tablet contains bismuth nitrate basic in the amount of 282 mg, bismuth oxide – 350 mg, heavy magnesium carbonate in the amount of 168.5 mg, magnesium oxide – 400 mg, sodium bicarbonate – 200 mg, buckthorn bark powder – 25 mg, calamus rhizome powder – 25 mg;
excipients: magnesium stearate, potato starch, talc.
Dosage form
Pills.
Main physicochemical properties: tablets from pinkish-brown to pinkish-purple in color with white and dark inclusions, oval in shape with a biconvex surface, with a score on one side of the tablet.
Pharmacotherapeutic group
Drugs for the treatment of peptic ulcer and gastroesophageal reflux disease. ATC code A02B X.
Pharmacological properties
Pharmacodynamics
Vicair® has a complex effect. Bismuth nitrate basic, sodium bicarbonate, and heavy magnesium carbonate have an antacid and astringent effect, buckthorn bark has a laxative effect, and calamus rhizome has an antispasmodic effect.
Pharmacokinetics
Data is missing.
Indication
As part of the complex therapy of peptic ulcer of the stomach and duodenum, functional dyspepsia, hyperacid gastritis.
Contraindication
Hypersensitivity to the components of the drug. Chronic and inflammatory processes of the intestines and gallbladder; hypoacid gastritis; gastrointestinal bleeding; severe renal dysfunction; acute febrile conditions.
Sea buckthorn bark: constipation of neurogenic and endocrine origin, spastic constipation, intestinal obstruction, bleeding, acute abdominal syndrome, appendicitis, acute gastroenterocolitis.
Special safety measures.
During treatment, you should follow a diet.
During treatment with the drug, it is necessary to monitor kidney function and the concentration of bismuth in the blood and urine. When taking the tablets, the stool is dark green or black.
It is recommended to take the drug 2 hours before or after taking other medications.
Interaction with other medicinal products and other types of interactions
When using the drug, the resorptive effect of tetracyclines is reduced, since the interaction of tetracyclines with drugs containing magnesium cations forms complexes that are poorly absorbed.
During treatment with Vicair®, other drugs containing bismuth should not be taken to prevent the risk of increasing bismuth levels in the blood.
Should not be used simultaneously with alkaloids, glycosides, enzyme preparations and antibiotics.
The drug reduces the absorption of coumarin derivatives.
Absorption of other drugs used together with Vicair® may be reduced. Therefore, the time interval between taking the drugs should be at least 2 hours.
Application features
You should not take antacids or consume milk half an hour before and half an hour after taking the drug, as the available gastric juice is needed to form a protective layer.
Long-term use of bismuth compounds is not recommended due to the occurrence of encephalopathy in rare cases. If the recommended dosage regimen is followed, the risk of this side effect is very small, however, it is not recommended to take other bismuth-containing drugs while taking this drug.
Use during pregnancy or breastfeeding
Vicair® should not be used during pregnancy. Use of the drug should be discontinued during breastfeeding.
Ability to influence reaction speed when driving vehicles or other mechanisms
Currently, there is no information about an adverse effect on the reaction speed when driving or working with other mechanisms.
Method of administration and doses
Take Vicair® orally after meals.
Take 1-2 tablets 3 times a day, washed down with ½ cup of warm water (it is advisable to crush the tablets beforehand).
The course of treatment is determined by the doctor depending on the nature and severity of the disease.
Children
There is no experience in children.
Overdose
Symptoms: nausea, vomiting, diarrhea.
Treatment: symptomatic.
Bismuth.
With frequent use of large doses of the drug, an overdose of bismuth is possible, which may manifest itself after 10 days with symptoms characteristic of renal failure (increased levels of bismuth in the blood plasma).
Buckthorn bark.
Symptoms: colicky abdominal pain, tenesmus, feeling of discomfort.
Adverse reactions
On the part of the digestive tract: increased frequency of bowel movements, which stops when the dose is reduced, nausea, vomiting, pigmentation on the tongue.
Central nervous system: headache.
From the blood and lymphatic system: hemoglobinemia.
General disorders: swelling of the gums and eyelids.
Other: allergic reactions including urticaria, rash, itching and swelling.
Bismuth.
Skin and subcutaneous tissue disorders: rash, itching.
On the part of the digestive tract: black or dark green stools.
On the part of the digestive tract: dehydration, decreased function of intestinal enzymes, atony of the large intestine, colicky pain.
Rhizome flakes.
On the part of the immune system: urticaria, skin rash, itching, swelling.
Expiration date
5 years.
Storage conditions
Store in the original packaging at a temperature not exceeding 25 ºС.
Keep out of reach of children.
Packaging
Tablets No. 10 in a strip; No. 10 in a blister; No. 10 in a blister, 2 blisters in a pack.
Vacation category
Without a prescription.
Producer
1. PJSC "Kyivmedpreparat".
2. PJSC "Halychpharm".
Location of the manufacturer and its business address
1. Ukraine, 01032, Kyiv, Saksaganskoho St., 139
2. Ukraine, 79024, Lviv, Opryshkivska St., 6/8.
Applicant
PJSC "Halychpharm".
Applicant's location
Ukraine, 79024, Lviv, Opryshkivska St., 6/8.
